|
T.TST
|
Another excerpt from the SA article -- "Here's an overview of peer...
|
|
T.TST
|
I don't think this is the conference bump. Last week was the conference...
|
|
T.TST
|
$10k a year for OTC fees and as RG pointed out, w did over a million shares...
|
|
T.TST
|
Hey 10-4. Here is what Seeking Alpha thinks about our valuation. Bioniche...
|
|
T.TST
|
I think volume picked up today and will pick up much more while Telesta is...
|
|
T.TST
|
Considering 50% of phase 3 completed drugs eventually get FDA approval, and...
|
|
T.TST
|
I don't get tired of reading this. "Bioniche (Telesta) could be the...
|
|
T.TST
|
I hope they don't come out with an analyst report this week. That would...
|
|
T.TST
|
I bought another 60k this month, so I guess the averaging down talk is...
|
|
T.TST
|
Our CEO stated that we would be submitting our final BLA data package with...
|
|
T.TST
|
Donald Olds (our COO) bought 60k shares a week and a half ago. Apparently he...
|
|
T.TST
|
We have or will have about 22 or 23 months of cash assuming no VMC sale. With...
|
|
T.TST
|
Good job Tson. I remember the days when I believed we had something in...
|
|
T.TST
|
Rage, the FDA told us we didn't need a second phase 3 trial, saving...
|
|
T.TST
|
We have close to 16mm in cash once the holdback and receivables are paid to...
|
|
T.TST
|
I would guess that no big news will come out of the FDA meeting this month...
|
|
T.TST
|
Let's be sure people understand what deficit means to Bioniche Telesta...
|
|
T.TST
|
Scouting for asymmetric opportunities in the small caps universe, I...
|
|
T.TST
|
Hey RG th problem with accepting 10mm (in lieu of the financing) is we have...
|
|
T.TST
|
According the the Pinks someone just paid $8.6B for their 49,600 shares...
|